This report analyzes the worldwide markets for Personalized Medicines in US$ Million by the following Segments: Targeted Therapeutics, and Tests & Lab Services.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 87 companies including many key and niche players such as -
- Abbott Molecular, Inc.
- Beckman Coulter Genomics
- bioM?rieux SA
- Bristol-Myers Squibb Company
- Dako Denmark A/S
- F. Hoffmann-La Roche Ltd.